» Articles » PMID: 32300296

Low Cholesterol Level Linked to Reduced Semantic Fluency Performance and Reduced Gray Matter Volume in the Medial Temporal Lobe

Overview
Specialty Geriatrics
Date 2020 Apr 18
PMID 32300296
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Hyperlipidemia has been proposed as a risk factor of dementia and cognitive decline. However, the findings of the relationship between cholesterol level and cognitive/brain function have been inconsistent. Here, using a well-controlled sample from the Parkinson's Progression Markers Initiative (PPMI), we investigated the probable non-linear relationship between plasma total cholesterol (TC) level, gray matter volume (GMv), and cognitive performance in 117 non-demented subjects (mean age, 61.5 ± 8.9 years), including 67 Parkinson's disease (PD) patients and 50 demographically matched controls. A quadratic relationship between semantic fluency (SF) performance and TC levels was identified. Within the subjects with a desirable TC level (TC < 200 mg/dl), low TC (lTC) levels were associated with reduced SF performance, as well as reduced GMv in three medial temporal regions [including bilateral anterior hippocampus (HIP)]. In contrast, no significant relationship between TC and cognition performance/GMv was found in individuals with a high cholesterol level (i.e., TC ≥ 200 mg/dl). Further region of interest (ROI)-based analysis showed that individuals with TC levels ranging from 100 to 160 mg/dl had the lowest GMv in the medial temporal regions. These findings suggest that low-normal TC level may be associated with reduced cognitive function and brain atrophy in regions implicated in neurodegenerative diseases, adding to a growing body of literature supporting a probable non-linear relationship between cholesterol level and brain health. However, this finding needs to be verified with other large public cohort data that do not include PD patients.

Citing Articles

Association of cardiovascular health with cognitive function and the mediating effect of depressive state.

Hu Y, Sun X, Guo C, Wu R, Dou J, Song S Front Aging Neurosci. 2025; 16:1465310.

PMID: 39744518 PMC: 11688292. DOI: 10.3389/fnagi.2024.1465310.


Combining Quantitative Susceptibility Mapping With the Gray Matter Volume to Predict Neurological Deficits in Patients With Small Artery Occlusion.

Tang X, He Z, Yang Q, Yang T, Yu Y, Chen J Brain Behav. 2024; 14(10):e70080.

PMID: 39363797 PMC: 11450255. DOI: 10.1002/brb3.70080.


Non-linear relationship between serum cholesterol levels and cognitive change among older people in the preclinical and prodromal stages of dementia: a retrospective longitudinal study in Taiwan.

Chang H, Chan P, Chiu P BMC Geriatr. 2024; 24(1):474.

PMID: 38816835 PMC: 11138028. DOI: 10.1186/s12877-024-05030-0.


Associations of Triglycerides and Atherogenic Index of Plasma with Brain Structure in the Middle-Aged and Elderly Adults.

Chen X, Bao Y, Zhao J, Wang Z, Gao Q, Ma M Nutrients. 2024; 16(5).

PMID: 38474800 PMC: 10933770. DOI: 10.3390/nu16050672.


Cholesterol-metabolism, plant sterols, and long-term cognitive decline in older people - Effects of sex and APOEe4.

Spinedi M, Clark C, Zullo L, Kerksiek A, Pistis G, Castelao E iScience. 2024; 27(2):109013.

PMID: 38327787 PMC: 10847741. DOI: 10.1016/j.isci.2024.109013.


References
1.
Wendell C, Zonderman A, Katzel L, Rosenberger W, Plamadeala V, Hosey M . Nonlinear associations between plasma cholesterol levels and neuropsychological function. Neuropsychology. 2016; 30(8):980-987. PMC: 5088056. DOI: 10.1037/neu0000298. View

2.
Shepardson N, Shankar G, Selkoe D . Cholesterol level and statin use in Alzheimer disease: I. Review of epidemiological and preclinical studies. Arch Neurol. 2011; 68(10):1239-44. PMC: 3211071. DOI: 10.1001/archneurol.2011.203. View

3.
Reitz C, Tang M, Schupf N, Manly J, Mayeux R, Luchsinger J . Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease. Arch Neurol. 2010; 67(12):1491-7. PMC: 3065942. DOI: 10.1001/archneurol.2010.297. View

4.
Kivipelto M, Ngandu T, Fratiglioni L, Viitanen M, Kareholt I, Winblad B . Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol. 2005; 62(10):1556-60. DOI: 10.1001/archneur.62.10.1556. View

5.
Wendell C, Waldstein S, Zonderman A . Nonlinear longitudinal trajectories of cholesterol and neuropsychological function. Neuropsychology. 2013; 28(1):106-12. PMC: 3932026. DOI: 10.1037/neu0000002. View